(NYSE MKT:OPTT), MONROE TOWNSHIP, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT), a leader in intelligent maritime systems and ocean energy solutions, today announced a partnership with Mythos AI to integrate advanced AI-driven autonomy software across OPT's fleet of WAM-V(R) Autonomous Surface Vehicles (ASVs) and PowerBuoy(R) platforms. This collaboration […]
(NASDAQ:NUWE), MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing the critical interplay between the heart and kidneys, today reported financial results for the third quarter ended September 30, 2025 and provided a business update on recent milestones
Company reports progress to file planned IND for (Z)-endoxifen in mBC with CRO selection and streamlined development programs for potential 2026-NDA enabling activities, including a Type C meeting with the FDA, to potentially accelerate (Z)-endoxifen in breast cancer risk reduction Appointed key leadership to drive (Z)-endoxifen development and evolve pathway to commercialization Atossa Therapeutics, Inc.
CIChecked (Commercial Investigations LLC), a woman-owned, New York State-licensed private investigative agency specializing in background screening and compliance services, today announced its recognition in the HRO Today's prestigious 2025 Baker's Dozen Employment Screening Ratings, securing 7th place in the overall rankings. https://mma.prnewswire.com/media/2820320/CIChecked___Overall_Enterprise_Pre_Employment_Screening_Leaders.jpg The company also earned recognition in three subcategories, including 7th in Quality of
Ocean Power Technologies and Mythos AI Partner to Advance Autonomous Maritime Capabilities GlobeNewswire November 12, 2025 MONROE TOWNSHIP, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT), a leader in intelligent maritime systems and ocean energy solutions, today announced a partnership with Mythos AI to integrate advanced AI-driven autonomy software
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum Company delivers steady performance and achieves key milestones across critical care, pediatrics, and hospital-based outpatient therapy GlobeNewswire November 12, 2025 MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions,
— Ample global spare capacity lowers risk of goods price inflation beyond tariffs as manufacturers trim inventories and purchasing — North American manufacturers report steepest drop in material purchases since May, signaling weaker production ahead — Chinese factories pull back buying, increasing spare capacity across Asia's suppliers — Europe's manufacturing sector recovery continues to make
Dubai, UAE, Nov. 12, 2025 (GLOBE NEWSWIRE) — At the Blockchain Life 2025 forum in Dubai — one of the world's biggest events on cryptocurrency and Web3 — BestChange announced its key ecosystem updates: a newly designed website, a mobile application, and a Telegram Mini App. The announcement was made in front of almost 17,000
BestChange Announces Major Platform Update at Blockchain Life 2025 Global Crypto Community Witnesses Major BestChange Platform Updates on the Main Stage GlobeNewswire November 12, 2025 Dubai, UAE, Nov. 12, 2025 (GLOBE NEWSWIRE) — At the Blockchain Life 2025 forum in Dubai — one of the world's biggest events on cryptocurrency and Web3 — BestChange announced
Groundbreaking Synovetin OA® targets pain and inflammation at the source, may slow progression, and provides up to a year of relief with just one treatment Exubrion Therapeutics today announced a major milestone in the nationwide adoption of Synovetin OA, its groundbreaking targeted medical radiotherapy for canine osteoarthritis (OA) – the licensing of the 100th veterinary